Pharmaceutical company payments to Japanese breast cancer practice guideline authors
Abstract Background The creation of breast cancer practice guidelines requires proper management of financial relationships with drug companies, as they can introduce conflicts of interest (COIs) among guideline authors. However, little is known about the specific landscape and fraction of financial...
Saved in:
Main Authors: | Anju Murayama (Author), Kenichi Higuchi (Author), Keerthana R. Byreddy (Author), Kugo Hinari (Author), Yuki Senoo (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cross‐sectional analysis of pharmaceutical industry payments to board‐certified breast cancer specialists in Japan
by: Anju Murayama, et al.
Published: (2024) -
Financial conflicts of interest in Japanese obstetrics and gynaecology clinical practice guidelines
by: Anju Murayama, et al.
Published: (2024) -
Financial relationships between board‐certified neurologists and the pharmaceutical industry in Japan
by: Anju Murayama, et al.
Published: (2024) -
Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
by: Yurie Kobashi, et al.
Published: (2019) -
Pharmaceutical Payments to Authors of Dermatology Guidelines After Publication
by: Torunn E Sivesind, et al.
Published: (2022)